BIOQUAL, Inc.
Preclinical Testing CRO
Show more...
Press Release, BIOQUAL, Inc. July 31, 2020 Rockville
SARS-CoV-2 infection protects against rechallenge in rhesus macaques
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Anti-PfGARP Activates Programmed Cell Death of Parasites and Reduces Severe Malaria
BIOQUAL involved in the fight against COVID-19
BIOQUAL, Inc.
is fully accredited by the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC) and has a long history of providing state-of-the-art facilities and trained, experienced research scientists, veterinarians and animal care personnel for clients involved in infectious disease investigations, cancer research, and a wide variety of other in vivo and In vitro studies.
Research Services
AIDS
Zika
Influenza
RSV
Malaria
Other Infectious Disease Areas
BIOQUAL’s laboratories are actively involved in the evaluation of vaccines, vaccine therapeutics, microbicides and drug therapies. In vitro services are available. These services include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation and other cell-based assays.